secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evommune, Inc. (EVMN)
CIK:        0002044725
Form:       8-K
Filed at:   2026-04-13T23:59:59+00:00
Accession:  0001193125-26-152864
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evommune hosts webcast on MRGPRX2 inhibition for migraine treatment
-------------------------------------------------------------------

- Presentation reviews migraine treatment landscape and potential role of MRGPRX2 inhibition.
- No new clinical data, financial results, or regulatory milestones disclosed.
- Webcast replay available on company IR website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2044725/000119312526152864/0001193125-26-152864-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2044725/000119312526152864/evmn-20260413.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-152864

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer